Â¥
14.77
Nov 8
New Key Statistics Module, Z-Score and F-Score
SZSE:002727 Key Ratios
Market Cap ¥ M | 8,803.00 |
Enterprise Value ¥ M | 8,681.36 |
P/E(ttm) | 57.25 |
PE Ratio without NRI | 26.42 |
Forward PE Ratio | 12.43 |
Price/Book | 1.14 |
Price/Sales | 0.49 |
Price/Free Cash Flow | 5.01 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.72 |
Revenue (TTM) ¥ M | 18,156.00 |
EPS (TTM) ¥ | 0.26 |
Beneish M-Score | -3.02 |
10-y EBITDA Growth Rate % | 18.90 |
5-y EBITDA Growth Rate % | 24.90 |
y-y EBITDA Growth Rate % | -68.30 |
EV-to-EBIT | 20.39 |
EV-to-EBITDA | 20.39 |
PEG | 1.06 |
Shares Outstanding M | 596.01 |
Net Margin (%) | 0.86 |
Operating Margin % | 3.95 |
Pre-tax Margin (%) | 1.59 |
Quick Ratio | 0.77 |
Current Ratio | 1.29 |
ROA % (ttm) | 0.92 |
ROE % (ttm) | 2.00 |
ROIC % (ttm) | 5.00 |
Dividend Yield % | 2.64 |
Altman Z-Score | 2.27 |
SZSE:002727 Number of Guru Trades
SZSE:002727 Volume of Guru Trades
Gurus Latest Trades with SZSE:002727
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002727 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Yixintang Pharmaceutical Group Co Ltd Insider Transactions
No Available Data